MagnaMedics Diagnostics BVMagnaMedics Diagnostics BV (founded in 2003) is primarily focusing its efforts on development of state of the art magnetic bead separation techniques. It is based on MagnaMedics' own IP for developing & producing nanoparticles with a magnetic core integrating several important research options for scientist.
Besides standard products, MagnaMedics Diagnostics BV offers interested parties specific “tailor made” solutions. Via its extensive distributor network – in which AMS Biotechnology plays a key role in Europe – specific nanoparticles become available when “standard” solutions are not good enough. It offers a flexible solution for nanoparticle issues like: size (300 nm – 5 μm), matrix selection, encapsulation of specific compounds (eg drug, luminescent) and surface compound functionalities. MagnaMedics' specific project approach offers its project partners quick insight in feasible solutions for any issue relating to the use of magnetic beads.